Menu Expand
Hotspots in Diabetes - ECAB

Hotspots in Diabetes - ECAB

Ambady Ramachandran

(2013)

Additional Information

Book Details

Abstract

Diabetes is one of the most important non-communicable lifestyle diseases. Diabetes is a multifaceted disorder which possibly influences and impacts body pathophysiology by different mechanisms and in varied ways. Diabetes has a very distinguished impact on cardiovascular system and plays a detrimental role in development of cardiovascular disorders. Metabolic memory is used to describe the impact of exposure to glucotoxicity, lipotoxicity and other metabolic disturbances, either as an adverse or a beneficial cell response which determines the later development of vascular complications. Terms such as metabolic imprint, legacy effect, glycemic memory or latent hyperglycemic damage are also used. Diabetes has significant impact on different facets of life. Diabetes has a distinguished but significant impact on development of various cancers. Diabetes has a positive, negative and even neutral impact on pathogenesis and progression of cancer depending upon the tumor site. On the contrary, cancer also has a significant effect on diabetes development and management. These facets tend to get overlooked in the study of diabetes development and management. All these aspects are being thoroughly covered in this project so as to facilitate better management of diabetics.


Table of Contents

Section Title Page Action Price
Front Cover Front Cover
Front Matter ia
Copyright id
ECAB Clinical Update:Diabetology ie
Hotspots in Diabetes if
About the Authors ig
Contents ii
ECAB Clinical Update InformationHOTSPOTS IN DIABETES i
Metabolic Memory in Diabetes 1
ABSTRACT 1a
KEYWORDS 1b
Introduction 1
Mechanism of Metabolic Memory 2
Clinical Proofs Supporting the Concept of Metabolic Memory 5
Clinical Evidence-Type 1 Diabetes 5
Clinical Evidence-Type 2 Diabetes 7
Therapeutic Aspects 8
The Indian Scenario 9
Summary 10
Key Messages 10
Postprandial Hyperglycemia 13
ABSTRACT 13a
KEYWORDS 13a
Introduction 13
The Postprandial Physiology 14
Postprandial Hyperglycemia in the Pathogenesis of Type 2 Diabetes 16
Consequences and Impact of Postprandial Hyperglycemia 18
Mechanisms of Vascular Damage by Postprandial Hyperglycemia 20
Abnormal Vasodilation 20
Aldolase Reductase Abnormalities 21
Glycation 21
Hypercoagulability 21
Endothelial Inflammatory Activity 22
Excess Oxidative Activity 22
Treatment Approaches to Postprandial Hyperglycemia 23
Diet and Physical Activity 23
Pharmacologic Therapy 24
Meglitinides 24
Disaccharidase Inhibitors 25
Exanatide 26
Liraglutide 26
DPP-IV Inhibitors 26
Pramlintide 26
Short-acting Insulin Analogs 26
Inhaled Insulins 27
Summary 27
Interrelation of Type 2 Diabetes and Cardiovascular Disease 32
ABSTRACT 32a
KEYWORDS 32b
Introduction 32
Peculiarities In Heart Diseases In Diabetes 34
Coronary Artery Disease (CAD) 34
Silent Myocardial Ischemia (SMI) 35
Congestive Heart Failure (CHF) 36
Acute Coronary Syndrome (ACS) 36
Pathogenesis of Cvd in Diabetes 37
Consequences of Elevated Blood Glucose 37
Obesity/Overweight 38
Oxidative Stress 38
Hypertension 39
Dyslipidemia 39
Insulin Resistance 40
Adipokines 41
Endothelial Damage 41
Kidney Disease and Microalbuminuria 42
Inflammation 43
Hypercoagulability 44
Treatment/Prevention of Cv Events 44
Clinical Trials Aiming To Reducethe The Cvd Risks By Intensive Glycemic Control 45
The Controversial Clinical Trials On Glycemic Control 46
Clinical Trials Aiming At Reducing Other Cardiovascular Risk Factors 47
Summary 47
Diabetes and Cancer 55
ABSTRACT 55a
KEYWORDS 55b
Introduction 55
Global Update 57
Liver Cancer and Diabetes 59
Obesity, Diabetes and Cancer 61
Free Fatty Acids 63
Chronic Inflammation and Oxidative Stress 64
Pancreatic Cancer and Diabetes 64
Diabetes and Breast Cancer 66
Diabetes and Colon Cancer 67
Diabetes and Ovarian Cancer 68
Diabetes and Non-Hodgkin's Lymphoma 68
Diabetes and Prostate Cancer 69
Diabetes and Endometrial Cancer 70
Diabetes and Lung Cancer 72
Type 1 and Type 2 Diabetes and Cancer 72
Hyperinsulinemia/Hyperglycemia in Cancer 73
All and Type 1 Diabetes 77
Cancer and Statins 77
Antidiabetic Drug and Cancer 79
Sitagliptin and Pancreatitis 81
Liraglutide and Cancer 82
Rosiglitazone and Risks of Cancer 82
Insulin and Cancer 82
Treatment of Cancer and Diabetes 84
Diabetes Mellitus and Cancer Treatment Strategies 86
Clinical Comments 89
Summary and Conclusion 91
ECAB Clinical Update: Diabetology Other Books in This Series 101
Insulins in Diabetes 101
Dietary Considerations in Diabetes 101
Cardiometabolic Risk in India 102
Glycemic Monitoring 103
Microvascular Complications in Diabetes 104
Oral Hypoglycemic Agents 105
Unconventional Organ Damage in Diabetes 105
Diabetes and Lifestyle 106
Lipids in Diabetes 107